• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLPTI
Longport Inc
20.0
0.0x
---
United StatesAKSY
Aksys Ltd
30.0
0.0x
---
United StatesHLTT
Healthtech Solutions Inc
9.6K
0.0x
---
United StatesGENX
Genex Pharmaceutical Inc
320.0
0.0x
---
United StatesDYXC
DiaSys Corp
2.6K
0.0x
---
United StatesNXNN
Nexeon Medsystems Inc
200.0
0.0x
---
As of 2024-09-21

Company Information

Longport, Inc. develops, manufactures, markets and sells ultrasound imaging systems. The Company focuses on high resolution medical ultrasound. The Company focuses on providing imaging systems that help in the prevention, assessment and treatment of medical conditions. The Company offers a high-resolution ultrasound (HRUS) imaging system, EPISCAN I-200, which utilizes ultrasound to image the skin and underlying soft tissue. EPISCAN I-200 can be connected to a range of interchangeable imaging probes that enable the imaging of the skin and underlying soft tissue at frequencies between 20 megahertz (MHz) and 50 MHz. EPISCAN is utilized in a range of clinical applications, as well as in research and development. EPISCAN enables the examination of tissue at a microscopic level. Its technology is used in a range of applications, such as wound assessment and prevention, dermatology, aesthetics, and research, including validation of processes and products that impact the skin.

Contact Information

Headquarters
1620 Baltimore Pike, P.O. Box 768CHADDS FORD, PA, United States 19317
Phone
610-361-9100
Fax
302-658-3694

Executives

President, Chief Financial Officer, Director
Paul Wilson
Chief Executive Officer, Director
Michael Boyd
Director
Brian Clymer
Director
Paul Quintavalle

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$20.00
Revenue (TTM)
$1.2M
Shares Outstanding
23.1M
Longport Inc does not pay a dividend.
Beta
---
EPS
$-0.06
Book Value
$0.04
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-114.85%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.